A detailed history of Taylor, Cottrill, Erickson & Associates, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Taylor, Cottrill, Erickson & Associates, Inc. holds 1,660 shares of ABBV stock, worth $273,883. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,660
Previous 1,660 -0.0%
Holding current value
$273,883
Previous $284,000 15.14%
% of portfolio
0.09%
Previous 0.08%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $23,218 - $27,114
150 Added 9.93%
1,660 $284,000
Q1 2024

May 02, 2024

SELL
$159.82 - $182.1 $47,946 - $54,630
-300 Reduced 16.57%
1,510 $274,000
Q3 2023

Nov 03, 2023

SELL
$133.59 - $154.65 $13,359 - $15,465
-100 Reduced 5.24%
1,810 $269,000
Q2 2023

Aug 02, 2023

SELL
$132.51 - $164.9 $6,625 - $8,245
-50 Reduced 2.55%
1,910 $257,000
Q4 2021

Feb 03, 2022

SELL
$107.43 - $135.93 $3.78 Million - $4.79 Million
-35,213 Reduced 94.73%
1,960 $265,000
Q3 2021

Oct 15, 2021

BUY
$106.4 - $120.78 $167,154 - $189,745
1,571 Added 4.41%
37,173 $4.01 Million
Q2 2021

Jul 20, 2021

BUY
$105.21 - $117.21 $56,918 - $63,410
541 Added 1.54%
35,602 $4.01 Million
Q1 2021

Apr 14, 2021

BUY
$102.3 - $112.62 $110,177 - $121,291
1,077 Added 3.17%
35,061 $3.79 Million
Q4 2020

Jan 25, 2021

BUY
$80.49 - $108.67 $128,864 - $173,980
1,601 Added 4.94%
33,984 $3.64 Million
Q3 2020

Oct 09, 2020

BUY
$85.91 - $100.83 $22,508 - $26,417
262 Added 0.82%
32,383 $2.84 Million
Q2 2020

Jul 14, 2020

BUY
$73.37 - $98.18 $57,301 - $76,678
781 Added 2.49%
32,121 $3.15 Million
Q1 2020

Apr 15, 2020

SELL
$64.5 - $97.79 $115,261 - $174,750
-1,787 Reduced 5.39%
31,340 $2.39 Million
Q4 2019

Jan 14, 2020

SELL
$72.13 - $90.25 $21,134 - $26,443
-293 Reduced 0.88%
33,127 $2.93 Million
Q3 2019

Oct 25, 2019

BUY
$62.98 - $75.72 $104,987 - $126,225
1,667 Added 5.25%
33,420 $2.53 Million
Q2 2019

Jul 26, 2019

BUY
$65.7 - $83.98 $262,471 - $335,500
3,995 Added 14.39%
31,753 $2.31 Million
Q1 2019

Apr 29, 2019

SELL
$77.14 - $90.79 $56,312 - $66,276
-730 Reduced 2.56%
27,758 $2.24 Million
Q4 2018

Jan 29, 2019

SELL
$77.85 - $96.01 $8,563 - $10,561
-110 Reduced 0.38%
28,488 $2.63 Million
Q3 2018

Oct 24, 2018

SELL
$88.91 - $98.84 $39,120 - $43,489
-440 Reduced 1.52%
28,598 $2.71 Million
Q2 2018

Jul 30, 2018

SELL
$89.78 - $106.23 $15,711 - $18,590
-175 Reduced 0.6%
29,038 $2.69 Million
Q1 2018

Apr 23, 2018

SELL
$92.01 - $123.21 $138,475 - $185,431
-1,505 Reduced 4.9%
29,213 $2.77 Million
Q4 2017

Jan 24, 2018

SELL
$89.56 - $98.21 $48,899 - $53,622
-546 Reduced 1.75%
30,718 $2.97 Million
Q3 2017

Oct 19, 2017

BUY
$69.85 - $89.22 $2.18 Million - $2.79 Million
31,264
31,264 $2.78 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Taylor, Cottrill, Erickson & Associates, Inc. Portfolio

Follow Taylor, Cottrill, Erickson & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.